1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (L) plus pembrolizumab (P) and sunitinib (S) treatment arms
    Meeting Abstract

    Grünwald, V.; Powles, T.; Kopyltsov, E.; Kozlov, V.; Alonso, G. T.; Eto, M.; Hutson, T.; Motzer, R.; Winquist, E.; Maroto, P.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649
    Meeting Abstract

    Möhler, M.; Shitara, K.; Garrido, M.; Salman, P.; Shen, L.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Bragagnoli, A. C.; Liu, T.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma
    Meeting Abstract

    Rejeski, K.; Sesques, P.; Berger, C.; Jentzsch, L.; Mougiakakos, D.; Frölich, L.; Bücklein, V.; Blumenberg, V.; Schmidt, C.; Jallades, L.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
    Meeting Abstract

    Gautschi, O.; Subbiah, V.; Konda, B.; Bauer, T.; McCoach, C.; Falchook, G.; Takeda, M.; Patel, J.; Weiss, J.; Peled, N.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer
    Meeting Abstract

    Leyvraz, S.; Hong, D. S.; Shen, L.; van Tilburg, C. M.; Tan, D. S. W.; Kummar, S.; Lin, J. J.; Doz, F.; McDermott, R.; Albert, C. M.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib (N plus C) vs sunitinib (S) for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial
    Meeting Abstract

    Bedke, J.; Powles, T.; Burotto, M.; Bourlon, M. T.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Clinical benefit with ripretinib as ≥ 4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study
    Meeting Abstract

    Bauer, S.; Heinrich, M.; George, S.; Zalcberg, J. R.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation
    Meeting Abstract

    Therkelsen, K.; Grommes, C.
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Pediatric post-mortem tissue donation during a pandemic: A model of collaboration
    Meeting Abstract

    Uceda, E.; Campbell, C.; McThenia, S.; Degliuomini, M.; Khakoo, Y.; Pisapia, D. J.; Greenfield, J.
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Pituitary carcinoma: A case of dramatic response to immunotherapy (ipilimumab + nivolumab) after failure with temozolomide
    Meeting Abstract

    Shah, S.; Manzoor, S.; Rothman, Y.; Hagen, M.; Prater, L.; Golnik, K.; Mahammedi, A.; Lin, A.; Bhabhra, R.; Forbes, J.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save